{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10704074", "DateCompleted": {"Year": "2000", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0962-9351", "JournalIssue": {"Volume": "8", "Issue": "4-5", "PubDate": {"Year": "1999"}}, "Title": "Mediators of inflammation", "ISOAbbreviation": "Mediators Inflamm"}, "ArticleTitle": "Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets.", "Pagination": {"StartPage": "205", "EndPage": "209", "MedlinePgn": "205-9"}, "Abstract": {"AbstractText": ["In a previous work we have shown that heparin, in the presence of ozone (O3), promotes a dose-dependent platelet aggregation, while after Ca2+ chelation with citrate, platelet aggregation is almost negligible. These results led us to think that aggregation may enhance the release of platelet components. We have here shown that indeed significantly higher amount of platelet-derived growth factor (PDGF), transforming growth factor beta1 (TGF-beta1) and interleukin-8 (IL-8) are released in a dose-dependent manner after ozonation of heparinised platelet-rich plasma samples. These findings may explain the enhanced healing of torpid ulcers in patients with chronic limb ischemia treated with O3 autohaemoteraphy (O3-AHT)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of General Physiology, University of Siena, Italy."}], "Identifier": [], "LastName": "Valacchi", "ForeName": "G", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bocci", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mediators Inflamm", "NlmUniqueID": "9209001", "ISSNLinking": "0962-9351"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticoagulants"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Platelet-Derived Growth Factor"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}, {"RegistryNumber": "13838-07-8", "NameOfSubstance": "acid citrate dextrose"}, {"RegistryNumber": "2968PHW8QP", "NameOfSubstance": "Citric Acid"}, {"RegistryNumber": "61D2G4IYVH", "NameOfSubstance": "Adenosine Diphosphate"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9005-49-6", "NameOfSubstance": "Heparin"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Adenosine Diphosphate"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticoagulants"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Blood Platelets"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Citric Acid"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Glucose"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Heparin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["blood", "metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects"], "DescriptorName": "Platelet Aggregation"}, {"QualifierName": ["metabolism", "physiology"], "DescriptorName": "Platelet-Derived Growth Factor"}, {"QualifierName": ["blood", "metabolism"], "DescriptorName": "Transforming Growth Factor beta"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Methods Enzymol. 1994;234:279-93", "ArticleIdList": ["7808295"]}, {"Citation": "Transfusion. 1998 Feb;38(2):156-9", "ArticleIdList": ["9531946"]}, {"Citation": "Am J Physiol. 1997 Mar;272(3 Pt 1):L504-11", "ArticleIdList": ["9124608"]}, {"Citation": "Platelets. 1999;10(2-3):110-6", "ArticleIdList": ["16801079"]}, {"Citation": "Br J Haematol. 1996 Apr;93(1):225-34", "ArticleIdList": ["8611466"]}, {"Citation": "Lipids. 1987 Mar;22(3):206-11", "ArticleIdList": ["3574001"]}, {"Citation": "J Clin Invest. 1992 Nov;90(5):2123-9", "ArticleIdList": ["1331181"]}, {"Citation": "J Biol Regul Homeost Agents. 1996 Apr-Sep;10(2-3):31-53", "ArticleIdList": ["9250885"]}, {"Citation": "Free Radic Biol Med. 1997;22(6):999-1006", "ArticleIdList": ["9034239"]}, {"Citation": "Methods Enzymol. 1994;233:380-5", "ArticleIdList": ["8015473"]}, {"Citation": "Perspect Biol Med. 1998 Autumn;42(1):131-43", "ArticleIdList": ["10766603"]}, {"Citation": "Vox Sang. 1995;68(4):205-9", "ArticleIdList": ["7660637"]}]}], "History": [{"Year": "2000", "Month": "3", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "3", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "3", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "1999", "Month": "1", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10704074", "PMC1781810", "10.1080/09629359990360"]}}], "PubmedBookArticle": []}